Table 5.

Univariate and multivariate analyzes of the risk of developing treated hypertension, myocardial infarction, stroke, hospitalization for hypertension and hospitalization for heart failure during the follow‐up according to BP strata. Those parameters showing significant predictive value for the predefined outcomes at univariate analysis, were adjusted for age, gender, body mass index, smoking, dyslipidaemia, and diabetes at multivariate analysis

Parameters	Unadjusted		Adjusted—Model 1		Adjusted—Model 2
	OR (95% CI)	P value	OR (95% CI)	P value	OR (95% CI)	P value
Composite outcome (MI + Stroke + any hospitalization)
White‐coat HT	1.716 (1.215‐2.425)	.002	1.791 (1.244‐2.578)	.002	2.360 (1.596‐3.489)	<.001
Masked HT	1.993 (1.255‐3.166)	.003	1.757 (1.066‐2.893)	.027	1.616 (0.948‐2.753)	.078
Sustained HT	0.610 (0.457‐0.814)	.001	0.628 (0.461‐0.854)	.003	0.503 (0.363‐0.698)	<.001
Outcome myocardial infarction
White‐coat HT	0.753 (0.263‐2.161))	.598	—	—	—	—
Masked HT	7.739 (3.657‐16.378)	<.001	5.062 (2.218‐11.550)	<.001	4.118 (1.692‐10.019)	.002
Sustained HT	0.294 (0.039‐0.624)	.001	0.327 (0.150‐0.714)	.005	0.279 (0.123‐0.636)	.002
Outcome stroke
White‐coat HT	1.206 (0.454‐3.206)	.707	—	—	—	—
Masked HT	2.443 (0.834‐7.159)	.103	—	—	—	—
Sustained HT	0.448 (0.207‐0.970)	.042	0.524 (0.237‐1.161)	.111	0.520 (0.234‐1.155)	.108
Outcome hospitalization for HT
White‐coat HT	1.926 (1.258‐2.947)	.003	1.927 (1.233‐3.013)	.04	2.608 (1.619‐4.202)	<.001
Masked HT	2.447 (1.422‐4.210)	.001	2.553 (1.446‐4.508)	.001	2.449 (1.335‐4.491)	.004
Sustained HT	0.450 (0.310‐0.653)	<.001	0.450 (0.302‐0.671)	<.001	0.325 (0.213‐0.496)	<.001
Outcome hospitalization for HF
White‐coat HT	3.130 (1.224‐8.007)	.017	3.449 (1.321‐9.007)	.011	4.334 (1.605‐11.699)	.004
Masked HT	5.074 (1.803‐14.285)	.002	4.214 (1.449‐12.249)	.008	3.545 (1.160‐10.837)	.026
Sustained HT	0.301 (0.114‐0.794)	.015	0.316 (0.117‐0.852)	.023	0.268 (0.096‐0.752)	.012

CI, confidence intervals; HF, heart failure; HT, hypertension; OR, odds ratio.